New PH Medications and Trials Get Local Update
Patients with pulmonary arterial hypertension in the Kettering area heard about new treatment options and upcoming trials.
Updated on Nov. 21, 2026 in Heart Disease

The Pulmonary Hypertension Warriors Support Group marked PH Awareness Month with a guest speaker on November 14, 2026, at South Dayton Presbyterian Church in Kettering. Dr. Jean Elwing of UC Health presented information on newly developed medications and upcoming trials for patients with Pulmonary Arterial Hypertension.
Why it matters
Pulmonary hypertension is often unknown to the public, and attendees heard about new treatments in development and trials that may suit different patient groups depending on their current medications. The session gave patients and caregivers a local channel to learn about research options at a time when the field is advancing.
The information came from a single guest-speaker presentation rather than a published study, so no sample size, trial design, or measured outcomes were reported. The specific medications and trials discussed were not named in the account of the event.
The players
Dr. Jean Elwing (UC Health)
A physician with UC Health who presented information on new medications and upcoming trials for Pulmonary Arterial Hypertension patients.
Mary Hale
The leader of the Pulmonary Hypertension Warriors Support Group in the Dayton area, who spoke about public awareness of pulmonary hypertension.
The details
Pulmonary Arterial Hypertension is a form of high blood pressure in the arteries of the lungs that makes the heart work harder to pump blood through them. According to the event report, new medications are being developed, and upcoming trials are open to different patient groups based on the medications they currently take. Support group leader Mary Hale noted that not everyone who uses oxygen has COPD, a reminder that pulmonary hypertension can be easy to overlook.
Timeline
November 14, 2026: PH Awareness Month event held at South Dayton Presbyterian Church in Kettering.
Health Landscape
Pulmonary arterial hypertension is a rare, serious form of high blood pressure in the lungs, and patient groups like the Pulmonary Hypertension Warriors have long relied on community education to close knowledge gaps. The emphasis on new medications and upcoming trials reflects an ongoing effort to bring research developments to patients outside major academic centers.
If you or someone you know has unexplained shortness of breath, fatigue, or dizziness on exertion, it is worth raising pulmonary hypertension with a doctor, since the condition is easy to mistake for other lung or heart problems. Anyone already managing this condition may want to ask their physician whether current or upcoming clinical trials could be relevant to their treatment.
The takeaway
Pulmonary hypertension is often unknown to the public, and local support groups are a practical place to learn about new treatments and trial options. Bring questions about your medications and eligibility for trials to your physician.
Further reading
For more on the conditions behind this kind of update, explore our Heart Disease coverage.
Source note: This article includes information reported by WDTN.


